Design and Engineering of VesiVax® HIV Immunogen Formulations”

Award Notice Posted

Solicitation number
75N93024C00018
Agency
Awarded
to Molecular Express, Inc.
Set-aside
Total Small Business

Opportunity facts

Contract number
75N93024C00018 Federal contract award
Place of performance
Rancho Dominguez, California 90220, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, has awarded contract 75N93024C00018 to Molecular Express, Inc. for the design and engineering of VesiVax® HIV Immunogen Formulations. The contract, valued at $1,999,866, will be performed from July 1, 2024, through June 30, 2026, with Rancho Dominguez, California, designated as the place of performance. The contract falls under NAICS code 541715 for Research and Development in the Physical, Engineering, and Life Sciences, and was originally sourced from RFP No. PHS 2020-1, with Christopher Ray serving as the Contract Specialist and Robert Corno as the Contracting Officer.

Notice text

Awarded contract 75N93024C00018 to MOLECULAR EXPRESS, INC for 1999866.00 on 2024-06-25.

Files

File Type Posted
Award Synopsis Molecular.pdf PDF

Notice history

Notice Type Posted
This notice Latest Award Notice
Design and Engineering of VesiVax® HIV Immunogen Formulations Original Award Notice

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors